AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05241925 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation, exercise
Description: Combined training (continuous aerobic + resistance) The protocol will consist of supervised exercise lasting 1h10min each session (5 min of warm-up, 30 min of aerobic exercise, 30 min of resistance exercise and 5 min of cool-down/relaxation).~Combined training (high-intensity interval (IAI) + resistance) - Supervised exercise lasting 30 min each session (5 min warm-up, 20 min IAI and 5 min cool-down/relaxation).~And Resistance Training~- Resistance exercise will be performed at 70-80% of one repetition maximum (1-RM); 2 to 3 sets of 8 to 12 repetitions. The main muscle groups will be trained using training equipment with free weights and body mass of the participants. Exercises included leg extension, seated bicep curl, squat, seated triceps extension, sit-up, seated shoulder press, and standing pulldown
Study NCT06464523 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face to face education
Description: In addition to the standard cervical cancer screening programme service, participants in this group received individual face-to-face health education on HPV and cervical cancer prevention through home visits and were given educational brochures. Participants in this group were interviewed a total of four times (four times face-to-face) during the research period.
Study NCT06464523 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online education
Description: In addition to the standard cervical cancer screening programme service, participants in this group received individual health education on HPV and cervical cancer prevention online via video call via WhatsApp application and were given a digital education brochure. Participants in this group were interviewed a total of four times (four times remotely) during the research process.
Study NCT05968807 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iParent2Parent Program
Description: iParent2Parent is an online peer support mentorship program that is based on the iPeer2Peer online peer support mentorship program, which has been established in multiple chronic disease populations as a self-management intervention, including in chronic pain and juvenile idiopathic arthritis populations. The iParent2Parent program connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship.
Study NCT06475482 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lip hydrant
Description: lip hydrant containing peppermint oil, perilla frutescens, and Emblica fruit extract or petroleum gel.
Study NCT06475482 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Petroleum gel
Description: Vaseline
Study NCT06308120 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ion Endoluminal System
Description: Participants in the test arm will undergo a diagnostic bronchoscopy with ION™ Endoluminal System.
Study NCT06308120 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: superDimension Navigation System and Accessories
Description: Participants in the control arm will undergo a diagnostic bronchoscopy with superDimension Navigation System and Accessories.
Study NCT04900688 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: LithoVue Elite
Description: LithoVue Elite is a disposable flexible ureteroscope that offer novel pressure sensory capacity
Study NCT05606991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CPAP Withdrawal
Description: Complete withdrawal of continuous positive airway pressure (CPAP) therapy for a 2-week period.
Study NCT06256718 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Educational Intervention
Description: Evidence-based strategy (PC TEACH)
Study NCT04096625 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: Active tDCS will be delivered at 2mA for 20 minutes.
Study NCT04096625 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Active tDCS
Description: Active tDCS will be delivered at 2mA for 20 minutes.
Study NCT04096625 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assertiveness Training Program (ATP)
Description: The Assertiveness Training Program (ATP) is a cognitive-behavioural therapy delivered in group sessions.
Study NCT04096625 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Assertiveness Training Program (ATP)
Description: The Assertiveness Training Program (ATP) is a cognitive-behavioural therapy delivered in group sessions.
Study NCT04096625 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: Sham tDCS, after 40 seconds of stimulation (2mA), a small current pulse was delivered every 550 msec (110 muA over 15 msec).
Study NCT04096625 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: Sham tDCS, after 40 seconds of stimulation (2mA), a small current pulse was delivered every 550 msec (110 muA over 15 msec).
Study NCT04778579 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARI-0001 cells
Description: Adult differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B1) conjugated with the co-stimulatory regions 4-1BB and CD3z
Study NCT06163261 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Physical activity
Description: The intervention group will receive an individualized and person-centred prescription of physical activity and exercise.
Study NCT04733092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lipiodol
Description: Lipiodol in emulsion with contrast agent
Study NCT04886050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LC350189 Tablet
Description: Subject will receive an LC350189 Tablet as single dose on Day 1 or Day 5
Study NCT04886050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LC350189 Capsule
Description: Subject will receive an LC350189 Capsule as single dose on Day 1 or Day 5
Study NCT05851950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: group rumination focused cognitive behavioural therapy
Description: Psychotherapy
Study NCT05851950 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: opus treatment
Study NCT05109507 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visitor Mindset
Description: Single-session, self-guided intervention
Study NCT05109507 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxing with Nature
Description: Single-session, self-guided intervention
Study NCT05149846 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Pre-conditioning
Description: Pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to PCI
Study NCT05744947 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Specific Readapt -DISCO complementary questionnaire rehabilitation
Study NCT04907383 — intervention group
Intervention type: OTHER
Intervention: quality of life
Description: QoL assessment
Study NCT04740541 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intakes (Reference protein drinks (Scandishake, Solcarb, Beneprotein) and cookies)
Description: Reference protein drinks (Scandishake, Solcarb, Beneprotein) and cookies to meet nutritional requirements, 5 levels of threonine intakes
Study NCT06092177 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periodontal surgery with virtual reality distraction
Description: Periodontal surgery to improve gingival contour and eliminate inflamed periodontal pockets
Study NCT06092177 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periodontal surgery without virtual reality distraction
Description: Periodontal surgery to improve gingival contour and eliminate inflamed periodontal pockets
Study NCT05210985 — intervention group
Intervention type: BEHAVIORAL
Intervention: Affordances in the Home Environment for Motor Development-Infant Scale
Description: Affordances in the Home Environment for Motor Development-Infant Scale is a parent-filled assessment to determine the nature and amount of factors affecting infant motor skill development in the home environment, including the availability of toys, materials, and the availability of spaces.
Study NCT05210985 — intervention group
Intervention type: BEHAVIORAL
Intervention: Peabody Developmental Motor Scales-2
Description: Peabody Developmental Motor Scales \| Second Edition (PDMS-2) combines in-depth assessment with training or remediation of gross and fine motor skills of children from birth through 5 years.
Study NCT05210985 — intervention group
Intervention type: BEHAVIORAL
Intervention: Test Of Sensory Functions In Infants (Tsfı)
Description: This test helps you identify infants with sensory integrative dysfunction-including those at risk for developing learning disabilities as they grow older. The TSFI provides objective criteria that allow you to determine whether, and to what extent, an infant has deficits in sensory functioning. Designed for use with children from 4 months to 18 months old, the TSFI provides an overall measure of sensory processing and reactivity, as well as scores on the following subdomains: Reactivity to Tactile Deep Pressure Visual Tactile Integration Adaptive Motor Function Ocular Motor Control Reactivity to Vestibular Stimulation
Study NCT06506357 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Good Girl Probiotics
Description: Participants will take one capsule of the Good Girl Probiotics supplement daily in the morning for eight weeks.
Study NCT05195112 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT921
Description: Active ingredient
Study NCT05195112 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal Saline
Study NCT05674253 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine + Hydrocortisone
Description: Patients will receive dexmedetomidine 0.7 ɥg/kg/hr IV infusion before aortic cross-clamping, and will be continued intra-operatively and in ICU till weaning from mechanical ventilation Patients also will also receive Hydrocortisone 100 mg intravenous (IV) before aortic cross-clamping then 100 mg every 8 hours after surgery which will be continued for 48 hours
Study NCT05120505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: The patients in this group will be obtain Metformin starting from 50mg everyday at night, and gradually increase to maximum tolerable dose of 1-2g per day according to weights of patients for 6 months.
Study NCT05120505 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The patients in this group will be obtain starch tablets (which had same appearance and size comparing to Metformin) starting from 50mg everyday to 1-2g per day according to weights of patients for 6 months.
Study NCT06500104 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Kefir peptide
Description: Dosage: 1.2 gram kefir peptide daily oral intake for 12 weeks
Study NCT06004375 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Neomune
Description: Neomune containing 4.8 g arginine and 2 g glutamine
Study NCT06004375 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Neomune
Description: Neomune containing 4.8 g arginine and 2 g glutamine
Study NCT04934436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sleeping glasses and earplug
Description: In this study, the effect of the chronotype-appropriate nursing care on the intervention group will be examined.
Study NCT06164288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human Amniotic Epithelial Stem Cell Injection
Description: The dose escalation is carried out according to the 3+3 ascending principle, and a total of 3 dose levels are set:~1. Dose Level 1: 1×106 cells/kg;~2. Dose Level 2: 2×106 cells/kg;~3. Dose Level 3: 3×106 cells/kg; Note: In this study, if the maximum tolerated dose (MTD) is not explored at dose level 3 (3×106 cells/kg), it will be discussed by the Safety Review Committee (SRC) to decide whether to proceed with further dose escalation or expansion to 6 patients.
Study NCT04314219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 50mg
Description: Cyclophosphamide as GVHD prophylaxis will be on day +3 and day +5
Study NCT04314219 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: Methotrexate as GVHD prophylaxis will be on day +1, day +3, and day +6
Study NCT05481515 — intervention group
Intervention type: DEVICE
Intervention: Pulse oximetry
Description: Pulse oximeters will be evaluated against routine arterial blood gas measurements
Study NCT05481515 — intervention group
Intervention type: DEVICE
Intervention: Spectrophotometry
Description: Spectrophotometry will be used to measure skin tone
Study NCT05047679 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Perioperative Pain Neuroscience Education
Description: Perioperative pain neuroscience education addresses modifiable preoperative risk factors, and in particular cognitive and emotional risk factors, such as fear of movement and pain catastrophizing (i.e., excessively negative orientation toward pain). This education is a cognitive-based therapeutic intervention which reconceptualizes pain, informs patients about what to expect from the evolution of their pain, de-emphasizes the patho-anatomical content and focuses on factors contributing to the development of pain. It explains this all within a biopsychosocial framework, which means that it aims to optimize patients' beliefs. Furthermore, it intends to reassure the patient about the decision to have surgery, to potentially decrease perioperative distress.
Study NCT05047679 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Perioperative Biomedical Education
Description: Perioperative biomedical education will discuss the anatomy, physiology and biomechanics of the lumbar spine with the patient. Additionally, the content of this education includes the expected course of postoperative back and leg pain, as well as ergonomic advice on patient-specific daily activities. This education will be given within a biomedical framework, which means that it aims to explain the patients' complaints and recovery while focusing on anatomy and biomechanics, as opposed to patients' beliefs and cognitions.
Study NCT06500104 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Glucose powder
Study NCT06069687 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MELPIDA
Description: A single intrathecal infusion of 10 mL at 1E14 vg/mL for a total dose of 1E15 vg
Study NCT04848727 — intervention group
Intervention type: OTHER
Intervention: Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT)
Description: The EIT system will be placed at the subject's bedside to collect EIT measurements: Ventilation distribution%, changes in regional aeration in arbitrary units (AU), dependent and non-dependent silent spaces. A data acquisition cart will also be placed at the subject's bedside to collect hemodynamic and respiratory parameters measurements including: Heart rate (HR), blood pressure (BP), respiratory rate (RR), fraction of inspired oxygen (FiO2), transcutaneous carbon dioxide (TcCO2), and peripheral oxygen saturation (SpO2) via bedside monitoring devices.~The LuMon belts for neonates are disposable single-patient use belts that are adhesive-free. EIT measurements and data will be collected on each timeperiods (t1 and t2) for approximately 15-30 minutes on invasive or non-invasive ventilatory support.
Study NCT05876637 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Left Nostril Breathing
Description: The participants which will show cardiovascular hyper reactivity towards CPT will be divided into 2 groups having 30 participants in each group. Experimental group will receive Left Nostril Breathing(slow, deep breath taken through your left nostril while closing your right nostril with your right thumb. Then just as gently exhale long, slowly, and completely through the left nostril, just as gently. It will be done while sitting) for 10 minutes twice a day for the duration of 12 weeks. Follow up will be taken through administration Cold pressor test after every 4,8 and 12 weeks.
Study NCT05876637 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional
Description: 30 participants will be recruited in conventional group which will receive simple deep breathing exercises of 3 sessions per week for the duration of 12 weeks.Follow up will be taken after every 4,8 and 12 weeks.
Study NCT04936165 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy
Description: Use 810-nm-photosource to irradiate the participants' brain and forearm for 10 minutes with a water-cooling radiator to keep it at 25 ± 0.5 ℃.
Study NCT05800158 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit
Description: A reverse transcription, real-time polymerase chain reaction (RT-qPCR) test for the qualitative detection of SARS-CoV-2.
Study NCT05260437 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CV2CoV (2 µg)
Description: Study vaccine was administered as a single intramuscular injection.
Study NCT05260437 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CV2CoV (4 µg)
Description: Study vaccine was administered as a single intramuscular injection.
Study NCT05260437 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CV2CoV (8 µg)
Description: Study vaccine was administered as a single intramuscular injection.
Study NCT05260437 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CV2CoV (12 µg)
Description: Study vaccine was administered as a single intramuscular injection.
Study NCT05260437 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CV2CoV (16 µg)
Description: Study vaccine was administered as a single intramuscular injection.
Study NCT05260437 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CV2CoV (20 µg)
Description: Study vaccine was planned to be administered intramuscularly. No vaccine was administered in the CV2CoV (20 µg) Group, since there were no participants enrolled in it.
Study NCT05676515 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: culture media
Description: spliting of biological material and use of three culture media
Study NCT06146933 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Glucometer Test
Description: blood glucose measurement using finger tip capillary blood using BGM
Study NCT06146933 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Refernce Measurement
Description: blood glucose measurement using finger tip capillary blood using reference method
Study NCT05966324 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: baxdrostat
Description: Baxdrostat is an aldosterone synthase inhibitor
Study NCT05405192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dostarlimab
Description: First four cycles of Dostarlimab will be given intravenously (IV) on day 1 of each of the 21-day cycle at a dose of 500 milligrams (mg). The next 16 cycles of Dostarlimab will be given on day 1 of each of the 42-day cycles at a dose of 1,000 mg.
Study NCT05175690 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostic Software as Medical Device
Description: AudibleHealth Dx is an investigational Dx SaMD consisting of an ensemble of software subroutines that interacts with a proprietary database of signal data signatures (SDS) using Artificial Intelligence/Machine Learning (AI/ML) to analyze forced cough vocalization signal data signatures (FCV-SDS) for diagnostic purposes. The intended use for the AudibleHealth Dx AI/ML-based Dx SaMD using FCV-SDS is for the diagnosis of acute and chronic illnesses.~The AudibleHealth Dx is a cloud-based AI/ML (locked ML) diagnostic software as medical device (Dx SaMD) with a mobile app based graphical user interface (GUI) designed to operate with COTS Android Operating System (OS) and Apple OS based mobile devices. The AudibleHealth Dx system uses a forced cough vocalization (FCV) signal data signature (SDS) to diagnose COVID-19 illness in ambulatory adults. Results are sent to ordering physicians, State Health Departments, and participants using Health Level 7 (HL7) compliant communication protocols.
Study NCT06321796 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MTP-101P
Description: MTP-101P is comprised of standardized dose of total fecal microbiota purified from the stool of healthy donors. Donors are carefully screened via health status questionnaires, physical examinations, reviews of comprehensive medical history, clinical laboratory evaluations, serologic and genomic tests for infectious diseases and metabolic health, and stool-related pathogen testing. The material from the donors is purified to remove the majority of non-bacterial material, washed, lyophilized, and provided to the patient in a sachet contained within a mixing bottle.~Duration: 12.5 Weeks
Study NCT06321796 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: Oral vancomycin is an antibiotic used for treating C. difficile-associated diarrhea and staphylococcal-induced enterocolitis.~Duration: 10 Days
Study NCT06321796 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Magnesium Citrate
Description: Magnesium citrate is a common over-the-counter laxative and bowel cleanse.~Duration: 1 Day
Study NCT06321796 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Magnesium Citrate
Description: Magnesium citrate is a common over-the-counter laxative and bowel cleanse.~Duration: 1 Day